PT - JOURNAL ARTICLE AU - Elisa, Benetti AU - Rossella, Tita AU - Ottavia, Spiga AU - Andrea, Ciolfi AU - Giovanni, Birolo AU - Alessandro, Bruselles AU - Gabriella, Doddato AU - Annarita, Giliberti AU - Caterina, Marconi AU - Francesco, Musacchia AU - Tommaso, Pippucci AU - Annalaura, Torella AU - Alfonso, Trezza AU - Floriana, Valentino AU - Margherita, Baldassarri AU - Alfredo, Brusco AU - Rosanna, Asselta AU - Mirella, Bruttini AU - Simone, Furini AU - Marco, Seri AU - Vincenzo, Nigro AU - Giuseppe, Matullo AU - Marco, Tartaglia AU - Francesca, Mari AU - Alessandra, Renieri AU - Maria, Pinto Anna TI - <em>ACE2</em> gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population AID - 10.1101/2020.04.03.20047977 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.03.20047977 4099 - http://medrxiv.org/content/early/2020/06/02/2020.04.03.20047977.short 4100 - http://medrxiv.org/content/early/2020/06/02/2020.04.03.20047977.full AB - In December 2019, an initial cluster of interstitial bilateral pneumonia emerged in Wuhan, China. A human-to-human transmission was assumed and a previously unrecognized entity, termed coronavirus-disease-19 (COVID-19) due to a novel coronavirus (SARS-CoV-2) was described. The infection has rapidly spread out all over the world and Italy has been the first European country experiencing the endemic wave with unexpected clinical severity in comparison with Asian countries.It has been shown that SARS-CoV-2 utilizes angiotensin converting enzyme 2 (ACE2) as host receptor and host proteases for cell surface binding and internalization. Thus, a predisposing genetic background can give reason for inter-individual disease susceptibility and/or severity. Taking advantage of the Network of Italian Genomes (NIG), here we mined whole-exome-sequencing data of 6930 Italian control individuals from five different centers looking for ACE2 variants. A number of variants with a potential impact on protein stability were identified. Among these, three more common missense changes, p.(Asn720Asp), p.(Lys26Arg), p.(Gly211Arg) were predicted to interfere with protein structure and stabilization. Rare variants likely interfering with the internalization process, namely p.(Leu351Val) and p.(Pro389His), predicted to interfere with SARS-CoV-2 spike protein binding, were also observed. Comparison of ACE2 WES data between a cohort of 131 patients and 258 controls allowed identifying a statistically significant (P value &lt;0,029) higher allelic variability in controls compared to patients. These findings suggest that a predisposing genetic background may contribute to the observed inter-individual clinical variability associated with COVID-19, allowing an evidence-based risk assessment leading to personalized preventive measures and therapeutic options.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesI declare availability to the data referred to in the manuscript and note links below.